Cita APA

Rastogi, P., Martin, M., Tolaney, S. M., Shao, Z. M., Cortés Castan, J., Fasching, P. A., & Harbeck, N. (2021). Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: Updated efficacy and Ki-67 analysis from the monarchE study.

Citación estilo Chicago

Rastogi, P., M. Martin, Sara M. Tolaney, Zhi Min Shao, Javier Cortés Castan, Peter A. Fasching, y Nadia Harbeck. Adjuvant Abemaciclib Combined With Endocrine Therapy for High-risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the MonarchE Study. 2021.

Cita MLA

Rastogi, P., et al. Adjuvant Abemaciclib Combined With Endocrine Therapy for High-risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the MonarchE Study. 2021.